Nanobiotix Logo

Nanobiotix

NANO | PA

Overview

Corporate Details

ISIN(s):
FR0010102145 (+2 more)
LEI:
969500667RSYIH8YL895
Country:
France
Address:
60 RUE DE WATTIGNIES, 75012 PARIS
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

Incorporated in 2003, Nanobiotix is a leading, late clinical-stage nanomedicine company pioneering new approaches to significantly change patient outcomes by bringing nanophysics to the heart of the cell. The Nanobiotix philosophy is one rooted in designing pioneer physical based approaches to bring highly effective and generalized solutions to address high unmet medical needs and challenges. Nanobiotix’s novel first-in-class, proprietary lead technology, NBTXR3, aims to expand radiotherapy benefits for millions of cancer patients. Furthermore, Nanobiotix’s Immuno-Oncology program has the potential to bring a new dimension to cancer immunotherapies.

Social Media

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for Nanobiotix. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-08-11 11:29
Major Shareholding Notification
Franchissements de seuils
French 111.3 KB
2025-07-11 11:18
Major Shareholding Notification
Franchissement de seuils
French 123.4 KB
2025-07-11 11:11
Major Shareholding Notification
Franchissement de seuils
French 122.5 KB
2025-06-20 15:17
Major Shareholding Notification
Franchissement de seuils
French 123.1 KB
2025-06-20 15:07
Major Shareholding Notification
Franchissement de seuils
French 123.4 KB
2025-06-10 22:15
Declaration of Voting Results & Voting Rights Announcements
Information mensuelle relative au nombre total de droits de vote et d’actions c…
French 110.8 KB
2025-06-10 22:15
Declaration of Voting Results & Voting Rights Announcements
Voting Rights and Shares Capital of the Company
English 112.0 KB
2025-05-28 08:00
Regulatory News Service
NANOBIOTIX participera à la conférence investisseurs annuelle Jefferies Global …
French 91.4 KB
2025-05-28 08:00
Regulatory News Service
NANOBIOTIX to Participate in the Jefferies Global Healthcare Investor Conference
English 88.9 KB
2025-05-21 22:15
Regulatory News Service
Nanobiotix Provides First Quarter 2025 Operational and Financial Update
English 173.9 KB
2025-05-21 22:15
Earnings Release
Nanobiotix fait le point sur sa trésorerie et son activité opérationnelle du p…
French 194.9 KB
2025-05-14 08:00
Declaration of Voting Results & Voting Rights Announcements
INFORMATION MENSUELLE RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS C…
French 110.7 KB
2025-05-14 08:00
Declaration of Voting Results & Voting Rights Announcements
Voting Rights and Shares Capital of the Company
English 112.2 KB
2025-05-12 08:00
Regulatory News Service
Nanobiotix participera à la 3ème conférence investisseurs annuelle H.C. Wainwri…
French 91.9 KB
2025-05-12 08:00
Regulatory News Service
Nanobiotix to Participate in the H.C. Wainwright 3rd Annual BioConnect Investo…
English 89.3 KB

Automate Your Workflow. Get a real-time feed of all Nanobiotix filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Nanobiotix via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2022-05-11 N/A Other Other 959,060 N/A

Peer Companies

Company Country Ticker View
XTL Biopharmaceuticals Ltd. Logo XTL Biopharmaceuticals Ltd. Israel XTLB
Zealand Pharma Logo Zealand Pharma Denmark ZEAL
Zelluna ASA Logo Zelluna ASA Norway ULTI
Zephyrus Wing Energies Ltd. Logo Zephyrus Wing Energies Ltd. Israel ZPRS
Ziccum AB Logo Ziccum AB Sweden ZICC